The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First report of safety/tolerability and preliminary antitumor activity of CAN-2409 in inadequate responders to immune checkpoint inhibitors for stage III/IV NSCLC.
 
Charu Aggarwal
Consulting or Advisory Role - AstraZeneca; BeiGene; Blueprint Genetics; Boehringer Ingelheim; Celgene; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech; Janssen; Lilly; Merck; Pfizer; Sanofi/Regeneron; Shionogi; Turning Point Therapeutics
Speakers' Bureau - AstraZeneca (I); Roche/Genentech (I)
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst)
 
Andrew Haas
Consulting or Advisory Role - Novocure; Olympus; Serpex Medical
 
Sarah W. Gordon
No Relationships to Disclose
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Bayer; Rakuten Medical
Research Funding - AstraZeneca; Merck
 
Peter M Lee
Research Funding - Candel Therapeutics
 
Christine M. Bestvina
Consulting or Advisory Role - Abbvie (I); AstraZeneca; Bristol-Myers Squibb/Celgene; Creative Educational Concepts; Curio Science; CVS; Genentech; Janssen; Jazz Pharmaceuticals; Novartis; OncLive Clinical Congress Consultants; Sanofi/Regeneron; Seagen; Takeda
Speakers' Bureau - Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Fabien Maldonado
Consulting or Advisory Role - Medtronic
Research Funding - Gala Therapeutics
 
Vamsidhar Velcheti
Honoraria - ITeos Therapeutics
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; GlaxoSmithKline; Lilly; Merck; Novartis
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); GlaxoSmithKline (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); RSIP Vision (Inst); Trovagene (Inst)
 
Roy S. Herbst
Leadership - Immunocore; Junshi Pharmaceuticals
Consulting or Advisory Role - Abbvie; ARMO Biosciences; AstraZeneca; Bayer; Biodesix; Bolt Biotherapeutics; Bristol-Myers Squibb; Candel Therapeutics; Checkpoint Therapeutics; Cybrexa Therapeutics; DynamiCure Biotechnology; eFFECTOR Therapeutics; EMD Serono; Foundation Medicine; Genentech/Roche; Genmab; Gilead/Forty Seven; Halozyme; Heat Biologics; HiberCell; I-Mab; Immune-Onc Therapeutics; Infinity Pharmaceuticals; Johnson and Johnson; Junshi Pharmaceuticals; Lilly; Loxo; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Ocean Biomedical; OncoCyte; Oncternal Therapeutics; Pfizer; Refactor Health; Ribon Therapeutics; Sanofi; Seagen; Shire; Spectrum Pharmaceuticals; STCube Pharmaceuticals Inc.; Symphogen; Takeda; TESARO; Tocagen; Ventana Medical Systems; WindMIL; Xencor
Research Funding - AstraZeneca; Genentech/Roche; Lilly; Merck
 
Susan D. Bell
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
 
Rachael Gillmor
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
 
Andrea Manzanera
Employment - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
 
Christopher Jon Matheny
Employment - Candel Therapeutics; GlaxoSmithKline
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline (Inst)
 
Estuardo Aguilar-Cordova
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Patents, Royalties, Other Intellectual Property - Candel Therapeutics
 
Laura K. Aguilar
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Patents, Royalties, Other Intellectual Property - Candel Therapeutics
 
Francesca Barone
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
Consulting or Advisory Role - Candel Therapeutics; SENDA Bioscience
Patents, Royalties, Other Intellectual Property - Kintai Therapeutics; Senda Bioscience
 
Paul Peter Tak
Employment - Candel Therapeutics
Leadership - Candel Therapeutics
Stock and Other Ownership Interests - Candel Therapeutics
 
Daniel Sterman
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Exigo Management Consultants; Flame Biosciences; Intuitive Surgical; Janssen Research & Development
Research Funding - Candel Therapeutics